Top 10 Diabetes Journals

Browse any public health website and look up diabetes and you’ll find several alarming statistics: it ranks sixth among non-communicable diseases causing death; affects 422 million individuals globally; and the prevalence of both type-1 and type-2 diabetes in children and adolescents, to highlight just a few.

Diabetes has an inescapable effect on our society, including our health systems, economies and most importantly, on people with diabetes and their families. Doctors, nurses, educators, health promoters and policymakers are all involved in diabetes care, so we’ve assembled our picks of some of the top international diabetes journals to help health professionals stay up-to-date with the latest research and news.

Here you will find the top 10 Diabetes journals ranked by the 2-year Journal Impact Factor (2-JIF) – a measure of the frequency with which the articles within the journal are cited in a particular 2-year period.

We have also included these other factors for each journal in our assessment to round off the picture.

Journal Metrics

Impact factor*

The Journal Impact Factor (JIF) is based on Web of Science data and only includes documents such as articles and reviews. The JIF helps to understand the importance of how often articles are cited by addressing the bias that arises from comparing citation numbers. This bias tends to advantage bigger journals over smaller ones, those published more often over those with fewer issues, and older journals over newer ones. This is because larger or older journals usually have more articles to be cited. By considering the impact factor, we can more fairly compare journals by taking into account these differences in size, publication frequency, and age. A JIF of 3 or more is considered good and 1 is average.

CiteScore*

CiteScore is based on Scopus data for all indexed documents, including articles, letters and editorials, as well as articles and reviews. The CiteScore for a particular year is calculated by dividing the number of citations to all indexed documents within the journal from that year and the three preceding years by the total number of documents published in the journal within that same period.

*Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area. Many academics value a journal’s Impact Factor over its Citescore; therefore they will use the impact factor to rank other journals in the same field.

SCImago Journal Rank (SJR)

The SCImago Journal Rank (SJR) indicator evaluates the prestige of academic journals by considering not only the number of citations a journal receives but also the prestige of the journals that issue these citations. An SJR >1.0 is above average. This measurement can be helpful to rank journals within the same field and category.

Source Normalised Impact per Paper (SNIP)

Source Normalised Impact per Paper (SNIP) weights citations based on the total number of citations in a subject field to provide a contextual, subject-specific metric. A SNIP over 1.0 means a journal has more citations than average.

Other Journal considerations

In addition to SJR ranking and journal impact factor, a good quality journal generally has the following characteristics:

1. It is indexed on PubMed, Google Scholar, Scopus, Web of Science or another reputable journal index.
2. It has an up-to-date website, a clear scope, extensive information for authors and readers, and a publicly visible editorial board consisting of appropriately qualified board members affiliated with accredited universities and research institutions.
3. Each article is assigned a Digital Object Identifier (DOI)

Top 10 Diabetes Journals

Selecting the right journal for your research is a critical step that can make or break the impact of your work. This is where a medcomms agency like Rx Communications can become an essential ally. With a deep understanding of the scientific publishing world and high levels of therapeutic area expertise, a medcomms agency worth its salt should be able to provide support at any stage of the publishing process. This includes assisting in finding journals that match your research area and larger aims, and shaping your manuscript so it reflects the ethos and audience of your chosen journal, as well as guiding you through the entire submission process including managing revisions, and planning for post-publication promotion and dealing with rejection.

Rx can increase your chances of not just getting published, but also ensuring your research makes the waves it deserves.

The Lancet Diabetes and Endocrinology

This monthly journal focuses on diabetes, endocrinology, and metabolism, offering original research, reviews, and comments. It addresses key issues and advancements in these fields, aiming to illuminate clinical practice and advocate for change.

• Website: https://www.thelancet.com/journals/landia/home
• Impact Factor: 44.5
• CiteScore: 58.1
• SJR: 8.217
• SNIP: 9.502
• H-Index: 151

Diabetes Care

"Diabetes Care," edited by Steven E. Kahn, is a journal intended for health care practitioners focusing on increasing knowledge, stimulating research, and promoting better management of people with diabetes. It publishes content that serves the expanded needs of all health professionals committed to diabetes patient care.

• Website: https://diabetesjournals.org/care
• Impact Factor: 16.2
• CiteScore: 27.8
• SJR: 6.008
• SNIP: 4.781
• H-Index: 399

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

This journal, affiliated with DiabetesIndia and the National Diabetes, Obesity and Cholesterol Foundation (NDOC), focuses on diabetes and metabolic syndrome. It publishes clinical research and reviews, aiming to provide healthcare professionals with insights into diabetes management and metabolic disorders.

• Website: https://www.sciencedirect.com/journal/diabetes-and-metabolic-syndrome-clinical-research-and-reviews
• Impact Factor: 10.0
• CiteScore: 15.4
• SJR: 1.495
• SNIP: 1.791
• H-Index: 71

Diabetologia

"Diabetologia," the official journal of the European Association for the Study of Diabetes (EASD), publishes high-quality articles on all aspects of diabetes, from basic science to clinical research. Edited by Hindrik Mulder, it is known for its cutting-edge content and is a leading publication in the field of diabetes research.

• Website: https://diabetologia-journal.org/
• Impact Factor: 8.2
• CiteScore: 17.6
• SJR: 3.349
• SNIP: 2.486
• H-Index: 250

Diabetes/Metabolism Research and Reviews

This journal publishes academic documents on clinical biochemistry and endocrinology, particularly focusing on diabetes and metabolism. It covers a range of topics including diabetes mellitus, type 2 diabetes, insulin resistance, and related metabolic conditions.

• Website: https://onlinelibrary.wiley.com/journal/15207560
• Impact Factor: 8.0
• CiteScore: 15.1
• SJR: 1.863
• SNIP: 2.396
• H-Index: 124

Diabetes

"Diabetes," edited by David A. D'Alessio, is a journal that publishes original research about the physiology and pathophysiology of diabetes mellitus. It covers a wide range of topics related to laboratory, animal, and human research in diabetes.

• Website: https://diabetesjournals.org/diabetes
• Impact Factor: 7.7
• CiteScore: 12.3
• SJR: 2.635
• SNIP: 1.654
• H-Index: 359

Diabetes and Metabolism

Published by the French Society for the Study of Diabetes, "Diabetes and Metabolism" is a journal that links hospital and research units in the field of diabetes. It publishes high-quality original research papers and is known for its comprehensive coverage of topics ranging from the epidemiology of diabetes to the latest in treatment and management strategies.

• Website: https://www.sciencedirect.com/journal/diabetes-and-metabolism
• Impact Factor: 7.2
• CiteScore: 12.0
• SJR: 1.849
• SNIP: 1.474
• H-Index: 99

Diabetes, Obesity and Metabolism

"Diabetes, Obesity and Metabolism" is an interdisciplinary journal focusing on clinical and experimental pharmacology and therapeutics related to metabolic and endocrine diseases. It publishes high-quality research and reviews in diabetes, obesity, and metabolism, and welcomes manuscripts on clinical data relating to novel devices, apps, glucose sensors, and insulin pumps used to improve glycemic control.

• Website: https://dom-pubs.onlinelibrary.wiley.com/journal/14631326
• Impact Factor: 5.8
• CiteScore: 11.8
• SJR: 2.048
• SNIP: 1.314
• H-Index: 142

Diabetes Technology and Therapeutics

"Diabetes Technology & Therapeutics," with an impact factor of 5.4, is a monthly peer-reviewed journal that covers all aspects of diagnosing and managing diabetes using cutting-edge devices, drugs, drug delivery systems, and software. It is the official journal of the Advanced Technologies & Treatments for Diabetes (ATTD) Conference and features content such as experiences of using closed-loop systems in type 1 diabetes pregnancy and advancements in continuous glucose monitoring.

• Website: https://home.liebertpub.com/publications/diabetes-technology-and-therapeutics/11
• Impact Factor: 5.4
• CiteScore: 11.6
• SJR: 2.374
• SNIP: 1.908
• H-Index: 97

Current Diabetes Reports

"Current Diabetes Reports" provides in-depth review articles by international experts on significant developments in diabetes. The journal presents clear, insightful, and balanced reviews emphasising recent important papers, covering current and emerging approaches to the diagnosis, treatment, management, and prevention of diabetes.

• Website: https://link.springer.com/journal/11892
• Impact Factor: 4.2
• CiteScore: 10.7
• SJR: 1.387
• SNIP: 1.613
• H-Index: 94

Publish or Perish - as true now as it ever was

In the high-stakes world of pharma and biotech, "Publish or Perish" isn’t just a catchy phrase—it’s the stark reality. For pharma companies and researchers, it’s not enough to develop breakthroughs; the real challenge lies in getting those findings recognised in top journals. In this game, it’s not just about playing your cards right; it’s about having a seasoned player on your team. With Rx Communications in your corner, you’ll be giving yourself the best chance to make an impact with your research. Explore our Publications Support Services here.

How to Stay Up-to-Date with Diabetes Research Developments

For pharma professionals and researchers working in the field of Diabetes, it is vital to stay abreast of the latest research advancements. To stay on top you might:

• Consider subscribing to our newsletter and receive updates to our top journal lists as well as other relevant industry and therapeutic developments as they happen.
• Register for an account with your selected journal to get direct access to new research as it's published.
• Customise an RSS feed for your selected journals to also further streamline the process, delivering the latest papers and articles directly to your digital doorstep.
• Setting up a Google alert with Diabetes research keywords to capture relevant news and studies from across the web.
• Lastly, don’t underestimate the power of social media; by following the publishers and journals in the field, you’ll tap into a community of shared knowledge and discourse.

References

• The top 10 causes of death, World Health Organization
• Diabetes, World Health Organization
• Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
• SCImago Journal & Country Rank
• Scopus

* Article originally written by Sarah Cahill and published in 2021, updated by Beth Howe and the Rx Team for 2024!